#$%^&*AU2016202866A120160526.pdf#####ABSTRACT A pharmaceutical composition comprising a combination of (A) (lS)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4methylphenyl]-1-thio-D-glucitol or a pharmaceutically acceptable salt thereof or a hydrate of the compound or the salt and (B) at least one member selected from the group consisting of insulin sensitizers, insulins, dipeptidyl peptidase IV inhibitors, a-glucosidase inhibitors, and GLP-1 mimetics.